Pilot batch production of drugs

EXPERIENCED BIOTECHNOLOGICAL PLANT (EBP) WAS ESTABLISHED IN 2001 ON THE BASIS OF THE INTEGRATED EXPERIMENTAL INSTALLATION OF IBCH RAS. IT IS A RESEARCH AND PRODUCTION PLATFORM FOCUSED ON WORKING WITH A WIDE RANGE OF PARTNERS FROM LARGE PHARMACEUTICAL COMPANIES AND MANUFACTURERS OF INNOVATIVE EQUIPMENT TO UNIVERSITIES AND START-UPS (the production license No. 11719-LS-P dated 25.06.2012, period of validity: indefinite).

THANKS TO THE FLEXIBLE, MODULAR ORGANIZATION EBP SUPPORTS PARTNERS AT VARIOUS STAGES OF PHARMACEUTICAL DEVELOPMENT OF INNOVATIVE AND BIOSIMILAR PRODUCTS WITH THE ASSISTANCE OF OTHER STRUCTURAL UNITS OF THE INSTITUTE.

EBP INCLUDES UNITS CARRIED OUT ALL STAGES OF THE TECHNOLOGICAL PROCESS FROM PRODUCER CELL CULTIVATION AND API PURIFICATION TO BOTTLING AND PACKAGING OF FINISHED DOSAGE FORMS. THE ORGANIZATION OF QUALITY CONTROL IS CARRIED OUT BY THE INDEPENDENT STRUCTURAL UNIT - QUALITY CONTROL DEPARTMENT.

RELEASED PRODUCTS:

1. HUMAN INTERFERON ALPHA-2B (IMMUNOMODULATOR);

2. LICOPID (IMMUNOMODULATOR);

3. MYELOPEPTIDES (IMMUNOMODULATOR);

4. DELTARAN (NEUROPROTECTOR);

5. RECOMBINANT HUMAN INSULIN AND ITS ANALOGUES;

6. DNA DIAGNOSTICS OF THROMBOPHILIA;

7. SYNTHETIC VACCINE AGAINST FOOT-AND-MOUTH DISEASE;

8. HUMAN GROWTH HORMONE;

9. RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

10. BISMETHYLHISTONE H1.3 (ANTICANCER DRUG);

11. HUMAN FOLLICLE STIMULATING HORMONE;

12. GLUCAGON (AMELIORATION OF HYPOGLYCEMIC COMA);

13. BLOOD CLOTTING FACTORS VII AND IX.